Literature DB >> 14597455

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong.

Kin Wing Choi1, Tai Nin Chau, Owen Tsang, Eugene Tso, Ming Chee Chiu, Wing Lok Tong, Po Oi Lee, Tak Keung Ng, Wai Fu Ng, Kam Cheong Lee, William Lam, Wai Cho Yu, Jak Yiu Lai, Sik To Lai.   

Abstract

BACKGROUND: Severe acute respiratory syndrome (SARS) has become a global public health emergency.
OBJECTIVE: To evaluate the characteristics and outcomes of patients with SARS in Hong Kong and to identify predictors of mortality.
DESIGN: Retrospective cohort study.
SETTING: Quarantine hospital for patients with SARS in Hong Kong. PATIENTS: 267 consecutive patients hospitalized from 26 February to 31 March 2003 for probable or confirmed SARS. MEASUREMENTS: Clinical, laboratory, and radiographic measures; 3-month mortality rate.
RESULTS: According to our case definition, there were 227 cases of confirmed SARS and 40 cases of probable SARS. Common presenting symptoms were fever (99% of patients), chills (74%), malaise (63%), and myalgia (50%). Laboratory findings included lymphopenia (73%), thrombocytopenia (50%), hyponatremia (60%), and elevated levels of lactate dehydrogenase (47%) and C-reactive protein (75%). During hospitalization, incidence of diarrhea (53%), anemia (53%), and acute renal failure (6%) increased. Sixty-nine patients (26%) required intensive care because of respiratory failure. The 3-month mortality rate was 12% (95% CI, 8% to 16%). Factors contributing to mortality were respiratory failure, acute renal failure, and nosocomial sepsis. On multivariate Cox regression, age older than 60 years (relative risk, 5.10 [CI, 2.30 to 11.31]; P < 0.001) and lactate dehydrogenase level greater than 3.8 micro kat/L at presentation (relative risk, 2.20 [CI, 1.03 to 4.71]; P = 0.04) were independent predictors of mortality.
CONCLUSION: Because of the longer follow-up period in our cohort, the mortality rate in these patients is higher than rates reported in previous studies. Advanced age and high lactate dehydrogenase level at presentation predict mortality. *For members of the Princess Margaret Hospital SARS Study Group, see the Appendix.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597455     DOI: 10.7326/0003-4819-139-9-200311040-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  167 in total

1.  Why SARS will not return: a polemic.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

Review 2.  Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases.

Authors:  Franklin R Cockerill; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Severe acute respiratory syndrome: What have we learned two years later?

Authors:  Lynn B Johnston; John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

4.  Clinical significance of hepatic derangement in severe acute respiratory syndrome.

Authors:  Henry-Lik-Yuen Chan; Ambrose-Chi-Pong Kwan; Ka-Fai To; Sik-To Lai; Paul Kay-Sheung Chan; Wai-Keung Leung; Nelson Lee; Alan Wu; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

5.  Clinical Features and Outcome of 65 Laboratory Confirmed Cases of H1N1 in Muscat, Sultanate of Oman.

Authors:  Sumant Pajankar; Salim Said Al Qassabi; Saud Mohamed Al Harthi
Journal:  Oman Med J       Date:  2012-05

6.  Severe acute respiratory syndrome: clinical and laboratory manifestations.

Authors:  Christopher W K Lam; Michael H M Chan; Chun K Wong
Journal:  Clin Biochem Rev       Date:  2004-05

7.  Clinical, Laboratory, and Radiologic Manifestation of SARS.

Authors:  Kar Neng Lai; Kenneth W. Tsang; Wing Hong Seto; Clara G. C. Ooi
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

8.  Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus.

Authors:  Kwonil Jung; Konstantin P Alekseev; Xinsheng Zhang; Doo-Sung Cheon; Anastasia N Vlasova; Linda J Saif
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.

Authors:  Mark J Cameron; Longsi Ran; Luoling Xu; Ali Danesh; Jesus F Bermejo-Martin; Cheryl M Cameron; Matthew P Muller; Wayne L Gold; Susan E Richardson; Susan M Poutanen; Barbara M Willey; Mark E DeVries; Yuan Fang; Charit Seneviratne; Steven E Bosinger; Desmond Persad; Peter Wilkinson; Larry D Greller; Roland Somogyi; Atul Humar; Shaf Keshavjee; Marie Louie; Mark B Loeb; James Brunton; Allison J McGeer; David J Kelvin
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

10.  A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Yun-Chung Cheung; Ping-Cherng Chiang; Chun-Hua Wang; Ying-Huang Tsai; Han-Ping Kuo; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.